CAS 31993-01-8
:6-Methyl-2-(2-phenyldiazenyl)-3-pyridinol
Description:
6-Methyl-2-(2-phenyldiazenyl)-3-pyridinol, with the CAS number 31993-01-8, is an organic compound that features a pyridine ring substituted with a methyl group and a diazenyl group. This compound is characterized by its azo functional group, which is known for its vibrant colors and is commonly used in dyes and pigments. The presence of the pyridine ring contributes to its potential as a ligand in coordination chemistry and may influence its solubility and reactivity. The methyl group enhances the lipophilicity of the molecule, potentially affecting its biological activity and interaction with other substances. Additionally, the diazenyl moiety can participate in various chemical reactions, including azo coupling and reduction processes. Overall, this compound's unique structural features make it of interest in fields such as organic synthesis, materials science, and potentially in biological applications, although specific applications would depend on further research and characterization.
Formula:C12H11N3O
InChI:InChI=1S/C12H11N3O/c1-9-7-8-11(16)12(13-9)15-14-10-5-3-2-4-6-10/h2-8,16H,1H3
InChI key:InChIKey=LOCPVWIREQIGNQ-UHFFFAOYSA-N
SMILES:N(=NC1=CC=CC=C1)C2=C(O)C=CC(C)=N2
Synonyms:- 3-Hydroxy-6-methyl-2-phenylazopyridine
- 3-Pyridinol, 6-methyl-2-(2-phenyldiazenyl)-
- 3-Pyridinol, 6-methyl-2-(phenylazo)-
- 3-Pyridinol, 6-methyl-2-[(E)-2-phenyldiazenyl]-
- 6-Methyl-2-(2-phenyldiazenyl)-3-pyridinol
- Sib 1757
- 6-Methyl-2-[(E)-phenyldiazenyl]pyridin-3-ol
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
SIB-1757
CAS:<p>SIB-1757 (6-methyl-2-[(E)-phenyldiazenyl]pyridin-3) is a selective antagonist of mGlu5 metabotropic glutamate receptor subtype (hmGlu5, IC50 : 0.4 μM)</p>Formula:C12H11N3OPurity:97.37%Color and Shape:SolidMolecular weight:213.24SIB 1757
CAS:<p>SIB 1757 is a potent, selective and orally active cannabinoid receptor 2 (CB2) agonist that was developed as a neuroprotective agent. It has been shown to be effective in the treatment of various nervous system diseases, including Parkinson's disease and Huntington's disease. SIB 1757 has been shown to have a potent antagonistic effect on glutamate receptors. This drug has also been shown to protect against the neurotoxicity associated with exposure to cytosolic calcium overload or glutamate receptor activation by blocking the release of calcium from intracellular stores. Furthermore, SIB 1757 has been shown to act as a dopamine D2 receptor antagonist and suppress striatal dopamine levels.</p>Formula:C12H11N3OPurity:Min. 95%Molecular weight:213.24 g/mol



